Onconvita: Unleashing the patient’s own power to fight cancer with a safe and effective vaccine
Total raised: $8.78M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.11.2023 | - | $8.78M | - |
Mentions in press and media 3
| Date | Title | Description |
| 15.10.2024 | Oncovita Appoints Stéphane Altaba as CEO | Oncovita, a Paris, France-based biotechnology company specializing in the development of therapeutic cancer vaccines and prophylactic vaccines, announced the appointment of Dr. Stéphane Altaba as its new Chief Executive Officer. Stéphane Al... |
| 29.11.2023 | Oncovita Receives €8M in Funding | Oncovita, a Paris, France-based biotech company specializing in the development of therapeutic and prophylactic vaccines, receives €8m in funding. The company won the “Innovations in biotherapies and bioproduction” call for projects under t... |
| - | Oncovita | “Onconvita: Unleashing the patient’s own power to fight cancer with a safe and effective vaccine” |